 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Biophytis downgraded to Reduce from Hold at Kepler Cheuvreux

HC Wainwright reissued their buy rating on shares of Biophytis (NASDAQ:BPTS Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 price objective on the stock. Biophytis Stock Down 2.7 % BPTS stock opened at $1.43 on Wednesday. ...

Biophytis (NASDAQ:BPTS) Given Buy Rating at HC Wainwright

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Biophytis (BPTS Research Report) today and set a price target of $15.00. The ... H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Biophytis (BPTS  Research...

H.C. Wainwright Remains a Buy on Biophytis (BPTS)

HC Wainwright reiterated their buy rating on shares of Biophytis (NASDAQ:BPTS  Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $15.00 target price on the stock. Biophytis Stock Performance BPTS stock opened at $1.36 on Tuesday. The business has a...

HC Wainwright Reaffirms Buy Rating for Biophytis (NASDAQ:BPTS)

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / August 8, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ('Biophytis'), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated...

Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe

Thinking about buying stock in Oncolytics Biotech, Amarin Corporation, Biophytis, bluebird bio, or VERSES AI? Thinking about buying stock in Oncolytics Biotech, Amarin Corporation, Biophytis, bluebird bio, or VERSES AI? PR Newswire NEW YORK, July 19, 2023 NEW YORK, July 19, 2023 /PRNewswire...

Thinking about buying stock in Oncolytics Biotech, Amarin Corporation, Biophytis, bluebird bio, or VERSES AI?

PARIS, FRANCE / ACCESSWIRE / July 18, 2023 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ('Biophytis'), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and...

Biophytis and SEQENS Sign a Partnership to Produce Sarconeos (BIO101) Active Compound

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 19, 2023 / Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (&laquo;Biophytis&raquo; or the &laquo;company&raquo;), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at...

Biophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International Congress

RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTEDPARIS FRANCE and CAMBRIDGE, MA / ACCESSWIRE / June 16, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS), (&laquo;Biophytis&raquo; or the...

Biophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been Adopted

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 5, 2023 / Biophytis SA (NasdaqCM:BPTS)(Euronext Growth Paris:ALBPS), ('Biophytis' or the 'Company'), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes...

Biophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of June

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.

Watchers	629
52-Wk Low	$1.00
52-Wk High	$9.02

Market Cap	$4.87M
Volume (M)	5,221.00
52-Wk High	$9.02
52-Wk Low	$1.00

BPTS Biophytis SA ADR

About

Feed

News

Fundamentals